GRACIE EXECUTIVE PROTECTION’s Post

Kudos. Brava. Kudos. There aren’t enough words…well let us allow some of the evidence to speak for itself… “And then, in terms of the faculty, it's even more so. It seems like every faculty person is the same exact background, older, white individual, most likely grew up in [State], probably went to school at [College]—as well—then practiced, and they're now kind of in their retirement. So, it seems like it's almost the same individual throughout the day. I mean, there are a few faculty here-and-there that are either younger or come from different backgrounds. And, often times, those are the ones that everyone likes to go to because they're more cognizant and aware of the challenges students are facing and are more empathetic to the day-to-day things that we have to do.” Equity, diversity and inclusion are NOT buzz words or solely aspirational goals. They are a matter of true commitments to professionalism and our supposed commitment to healthcare and to do no harm! #equitydiversityinclusion #inclusiveleadership #belonging #healthequity #healthcareethics #academicmedicine #dentaleducation #healthjustice

Today, we celebrate the spirit of freedom, unity, and the pursuit of excellence that defines our great nation The United States of America! As you enjoy the fireworks, barbecues, and quality time with loved ones, ensuring you have the freedom to focus on what truly matters. Wishing you a safe and joyful Fourth of July! 🎉 #IndependenceDay #FourthOfJuly #CelebrateFreedom #YourBusinessOurPriority  #TripointAdministrativeServices

CYTOMOS' TRANSFORMATIVE CELL ANALYSIS TECHNOLOGY Dr Lindsay Fraser - Cytomos' Chief Scientific Officer - delivered a great presentation on Cytomos' groundbreaking AuraCyt™️ cell analysis technology at the BIA’s 2023 BioProcessUK Dragon’s Den session held on 30 November.   AuraCyt™️ is securing leading industry recognition as a technological innovation that provides information on cell properties that no other process analytical technology (PAT) can. The capability to collect a multitude of data that measures the intrinsic properties of individual cells in real-time, and to obtain a unique profile for subsequent downstream analysis and characterisation, is set to radically change the way that processes are monitored, whilst transforming velocity in biopharmaceutical R&D and fundamentally changing bioprocess PAT adaptation.   The fast and scalable AuraCyt™️ platform closely monitors a broad range of individual cell features simultaneously, to provide label-free, unbiased, consistent, accurate and reliable predictive analytics for biomanufacturing and other applications. AuraCyt™️ can save and optimise batches, addressing pressing industry needs for smarter, less labour-intensive, and more automated processes capable of driving down biomanufacturing costs and realising scale-out in the manufacture of personalised, regenerative medicines.   The AuraCyt™️ platform improves the pace and accuracy of single cell analysis. The ground-breaking technology harnesses the power of dielectric spectroscopy and Cytomos’ proprietary silicon chip sensors to enable researchers and scientists across the life science industry to generate unique fingerprints to characterise cells without the requirement for labels. The technology has the potential to be incorporated in-line, allowing real-time monitoring of cell manufacturing events and predicting manufacturing success. AuraCyt™️ is a compatible asset that is usable both alongside flow cytometry technologies or on its own.

We are proud of what we achieved in 2023 with your support and are eager to see what we will accomplish together in the next year! Ensuring equity and justice for all Georgians will remain our top priority. Learn more about the strides we made this year in our latest newsletter, The Watcher: https://conta.cc/47dtujw #GeorgiaWatch

Does your business use remote workers? Consider attending the below presentation.

Dive deep into the heart of T.A. Schifsky & Sons, Inc.! Discover the driving force behind their success, the enduring family legacy, and the remarkable journey from small beginnings to towering achievements in this heartfelt interview. https://bit.ly/3UfV9gF

We are the leaders of Louisiana Title and are here to guide you! We hope all of our members feel the love! What's your favorite part about being a member of LLTA? Tell us in the comments below! 😍 #LLTA #TitleIndustry

Ernest M. Williams: Page about Ernest M. Williams

Redemption by Lisa Gerrard:

ICYMI: Robert D. Hatton: Page about Robert D. Hatton